Organovo (ONVO) Holdings announced that Eli Lilly (LLY) and Company will acquire Organovo’s FXR program, including its lead asset, FXR314. Under this transaction, Organovo will receive an ...
Following the announcement, shares in Organovo were trading a hefty 270% higher by lunchtime Tuesday. The deal will see Lilly acquire Organovo’s FXR program, including its lead asset, FXR314. All the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback